Related Experiment Video
Updated: Sep 22, 2025

07:08
A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System
Published on: April 6, 2021
5.1K
Plasmonic Fiberoptic Absorbance Biosensor (P-FAB) for Rapid Detection of SARS-CoV-2 Nucleocapsid Protein
M Divagar1, R Gayathri1, Rahiel Rasool1
1Biomedical Engineering GroupDepartment of Applied MechanicsIndian Institute of Technology Madras Chennai 600036 India.
Summary
A new plasmonic fiber optic absorbance biosensor (P-FAB) offers rapid, wash-free COVID-19 diagnosis by detecting SARS-CoV-2 nucleocapsid protein. This point-of-care test shows promise as a faster, more accessible alternative to RT-PCR.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Infectious Disease Diagnostics
Background:
- Current COVID-19 diagnostic methods like RT-PCR are expensive and time-consuming.
- SARS-CoV-2 nucleocapsid protein is an abundant biomarker for infection.
- There is a need for rapid, point-of-care diagnostic tools.
Purpose of the Study:
- To develop a rapid, wash-free plasmonic fiber optic absorbance biosensor (P-FAB) for SARS-CoV-2 N-protein detection.
- To optimize sensor components, including optical fiber material and gold nanoparticle (AuNP) label size.
- To establish a sensitive and efficient point-of-care diagnostic strategy.
Main Methods:
- A sandwich assay was designed using a U-bent fiber optic sensor probe and AuNP labels.
- Evanescent wave absorbance (EWA) sensitivity was utilized for detection.
- Optical fiber materials (silica vs. polymeric) and AuNP sizes (20, 40, 60 nm) were evaluated.
Main Results:
- The P-FAB strategy demonstrated high sensitivity and a low limit of detection (LoD).
- Fused silica/glass optical fiber (GOF) and ~40 nm AuNP labels yielded an LoD of ~2.5 ng/mL.
- Detection was achieved within a rapid 10-minute read-out time.
Conclusions:
- The developed P-FAB is a promising technology for rapid, point-of-care COVID-19 diagnosis.
- This biosensor offers a sensitive and efficient alternative to conventional diagnostic methods.
- Further development for a point-of-care device and preclinical studies are underway.

